Pentwater Capital Management’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-440,000
Closed -$10.1M 201
2022
Q2
$10.1M Buy
440,000
+325,000
+283% +$7.59M 0.12% 76
2022
Q1
$2.51M Buy
+115,000
New +$2.39M 0.03% 100
2021
Q4
Sell
-3,000,000
Closed -$62.8M 269
2021
Q3
$62.8M Sell
3,000,000
-6,005,500
-67% -$131M 0.64% 27
2021
Q2
$207M Sell
9,005,500
-494,500
-5% -$11.4M 1.71% 14
2021
Q1
$210M Buy
9,500,000
+9,341,984
+5,912% +$216M 2% 14
2020
Q4
$2.95M Hold
158,016
0.04% 108
2020
Q3
$2.29M Buy
158,016
+50,000
+46% +$636K 0.03% 116
2020
Q2
$1.21M Hold
108,016
0.02% 98
2020
Q1
$1.08M Buy
108,016
+18,616
+21% +$260K 0.02% 84
2019
Q4
$1.47M Sell
89,400
-50,600
-36% -$679K 0.02% 92
2019
Q3
$1.69M Sell
140,000
-10,000
-7% -$137K 0.03% 96
2019
Q2
$2.19M Buy
+150,000
New +$2.22M 0.02% 111

Other funds holding CHNG

Pentwater Capital Management's CHNG Position: Q3 2022 in Review

Pentwater Capital Management sold out of Change Healthcare Inc. Common Stock (CHNG) in Q3 2022, closing a stake of 440,000 shares — an estimated $10.1M sold.

Pentwater Capital Management first reported a position in CHNG in Q2 2019 and held it in 12 quarters. The position peaked at $210M in Q1 2021. 263 funds tracked by Wall St. Rank hold CHNG as of Q3 2022.

  • Pentwater Capital Management reported no remaining Change Healthcare Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Pentwater Capital Management sold 440,000 Change Healthcare Inc. Common Stock shares in Q3 2022, an estimated $10.1M.
  • Pentwater Capital Management first reported a position in Change Healthcare Inc. Common Stock in Q2 2019 and held it in 12 quarters.
  • Pentwater Capital Management's Change Healthcare Inc. Common Stock position peaked at $210M in Q1 2021.
  • 263 funds tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q3 2022.

Based on Pentwater Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.